SCHEMBL3962080

SCHEMBL3962080

c1ccc(-c2nc(NCCc3c[nH]c4ccccc34)cc(-c3cccnc3)n2)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.58
CCND1 P24385 2/20 0.58
GBA1 P04062 1/20 0.58
CYP1A2 P05177 4/20 0.54
CYP3A4 P08684 4/20 0.54
CYP2D6 P10635 4/20 0.54
CYP2C19 P33261 4/20 0.54
CLK4 Q9HAZ1 4/20 0.54
USP2 O75604 3/20 0.54
HSD17B10 Q99714 3/20 0.54
CYP2C9 P11712 2/20 0.54
ALDH1A1 P00352 2/20 0.54
ALOX15 P16050 2/20 0.54
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
CCNT1 O60563 1/20 0.49
CCNA2 P20248 1/20 0.49
CDK2 P24941 1/20 0.49
CDK9 P50750 1/20 0.49
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2237738 0.93 GBA1 (0.63) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL11968310 0.91 GBA1 (0.49) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL2235936 0.91 GBA1 (0.52) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL3715061 0.91 GBA1 (0.55) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL2240341 0.90 CDK4 (0.50) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL2237840 0.90 CYP1A2 (0.49) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL2244808 0.90 SPR (0.59) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL2239769 0.90 CYP1A2 (0.49) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL2237986 0.90 CYP1A2 (0.55) CDK4CCND1GBA1CYP1A2CYP3A4
SCHEMBL2241055 0.90 CYP3A4 (0.51) CDK4CCND1GBA1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP claimed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO claimed
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP claimed
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP disclosed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO disclosed
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed